Key Points
New Delhi: In 2019, between 3 and 10.4 lakh people in India died due to bacterial antimicrobial resistance (AMR), a condition in which pathogenic bacteria no longer respond to antibiotics, according to the new Global Research on Antimicrobial Resistance (GRAM) Project..
The findings, published Tuesday in The Lancet, also said that over 39 crore deaths caused directly or indirectly by antibiotic-resistant infections are estimated to occur worldwide by 2050...
The Lancet report added that 29.9 lakh people died in the country either directly from or due to conditions triggered by sepsisblood poisoning in which the body has an extreme reaction to infection, and whose management has become difficult due to AMR, a widely recognised global public health emergency...
The latest findings come after the annual report by the Indian Council of Medical Research (ICMR)s Antimicrobial Resistance Research and Surveillance Network (IAMRSN), released last week, which revealed the alarming presence of superbugspathogens resistant to multiple antibiotics and extremely difficult to treatin 21 of the countrys leading hospitals, from 2017 to 2023...
It added that each year between now and 2050, about 19.1 lakh people worldwide could potentially die as a direct result of AMR.. Over the same period, the number of global deaths in which AMR bacteria may play a role will increase by almost 75 percent from 47.2 to 82.2 lakh per year, the report said.. While the number of AMR deaths globally among children under five is projected to halve by 2050, that among people 70 years and older may increase twofold, the report added...
You might be interested in
All about antimicrobial resistance, the silent pandemic affecting millions
24, Nov, 23People have become so accustomed to popping pills, like candy, prescribed by pharmacists. Now, this practice has caused the biggest killer in the world - antimicrobial resistance.
Superbugs behind fatal blood infections in India rapidly growing resistant to last-resort antibiotics
25, May, 24Findings published in Lancet based on ICMR data collected from 14 states. Study to help monitor anti-microbial resistance & tailor region-specific treatment plans, researchers say.